Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 6, 2014, Pages 2045-2051

  Elias, Paula C L ^a   Martinez, Edson Z ^a   Barone, Bruno F C ^a   Mermejo, Livia M ^a   Castro, Margaret ^a   Moreira, Ayrton C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; CUSHING SYNDROME; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; INTERMETHOD COMPARISON; LATE NIGHT SALIVARY CORTISOL; LIQUID CHROMATOGRAPHY; MALE; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; AGED; CIRCADIAN RHYTHM; CUSHING SYNDROME; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SALIVA; YOUNG ADULT;

EID: 84902324733     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4262     Document Type: Article

References (40)

1. Aron DC. Cushing's syndrome: why is diagnosis so difficult? Rev Endocr Metab Disord. 2010;11:105-116.
2. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism. 1979;28:955-977.
3. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev. 1998;19:647-672.
4. Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC. Outpatient screening for Cushing's syndrome: the sensitivity of the combination of ci rcadian rhythm and overnight dexamethasone sup-pression salivary cortisol tests. J Clin Endocrinol Metab. 1999;84: 878-882.
5. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab. 1998; 83:2681-2686.
6. Nieman LK Biller BM Findling JW et al The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practic e Guideline J Clin Endocrinol Metab. 2008 93 1526-1540.
7. Manetti L, Rossi G, Grasso L, et al. Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and ur inary cortisol. Eur J Endocrinol. 2013;168:315-321.
8. Nunes ML, Vattaut S, Corcuff JB, et al. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitali zed and ambulatory patients. J Clin Endocrinol Metab. 2009; 94:456-462.
9. Deutschbein T, Petersenn S. Screening for Cushing's syndrome: new immunoassays require adequate normative data. Horm Metab Res. 2013;45:118-123.
10. Zhang Q, Dou J, Gu W, Yang G, Lu J. Reassessing the reliability of the salivary cortisol assay for the diagnosis of Cushing syndrome. J Int Med Res. 2013;41:1387-1394.
11. Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract. 2009;15:335-342.
12. Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab. 2003;88:4153-4157.
13. Kidambi S, Raff H, Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol. 2007;157:725-731.
14. Friedman TC, Ghods DE, Shahinian HK, et al. High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis a nd exclusion of Cushing's syndrome requires multiple testing. Horm Metab Res. 2010;42:874-881.
15. Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Müller B. Reproducibility of nightt ime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab. 2005;90:5730-5736.
16. Petersenn S, Newell-Price J, Findling JW, et al. High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf). 2014;80:261-269.
17. Castro Md, Moreira AC. Screening and diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol. 2007;51:1191-1198.
18. Sonino N, Boscaro M, Fallo F, Fava GA. A clinical index for rating severity in Cushing's syndrome. Psychother Psychosom. 2000;69: 216-220.
19. Santiago LB, Jorge SM, Moreira AC. Longitudinal evaluation of the development of salivary cortisol circadian rhythm in infancy. Clin Endocrinol (Oxf). 1996;44:157-161.
20. Vieira JG, Nakamura OH, Carvalho VM. [Measurement of free urinary cortisol and cortisone using liquid chromatography associated with tandem mass spectrometry method]. Arq Bras Endocrinol Metabol. 2005;49:291-298.
21. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC; 2003.
22. Box G, Tiao GC. Bayesian Inference in Statistical Analysis. Reprint ed. New York, NY: Wiley-Interscience; 1992.
23. Bianchi MT, Alexander BM, Cash SS. Incorporating uncertainty into medical decision making: an approach to unexpected test results. Med Decis Making. 2009;29:116-124.
24. Motulsky H. Intuitive Biostatistics. New York, NY: Oxford University Press; 1995.
25. Cipoli DE, Martinez EZ, de Castro Md, Moreira AC. Clinical judgment to estimate pretest probability in the diagnosis of Cushing's syndrome under a Bayesian perspective. Arq Bras Endocrinol Metabol. 2012;56:633-637.
26. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17:245-261.
27. Chriguer RS Elias LL da Silva IM Jr Vieira JG Moreira AC de Castro M Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies J Clin Endocrinol Metab. 2005 90 5978-5984.
28. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553-1562.
29. Carrasco CA, Garcí a M, Goycoolea M, et al. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system. Endocrine. 2012;41:487-493.
30. Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN. Diagnostic value of salivary cortisol in Cushing's syndrome (CS). Clin Endocrinol (Oxf). 2009;70:516-521.
31. Trilck M, Flitsch J, Lü decke DK, Jung R, Petersenn S. Salivary cortisol measurement-A reliable method for the diagnosis of Cushing's syndrome. Exp Clin Endocrinol Diabetes. 2005;113:225-230.
32. Karlamangla AS, Friedman EM, Seeman TE, Stawksi RS, Almeida DM. Daytime trajectories of cortisol: demographic and socioeconomi c differences-findings from the National Study of Daily Experiences. Psychoneuroendocrinology. 2013;38:2585-2597.
33. Champaneri S,XuX, CarnethonMR,et al. Diurnal salivary cortisol and urinary catecholamine s are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism. 2012;61: 986-995.
34. Gunther DF, Bourdeau I, Matyakhina L, et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab. 2004;89:3173-3182.
35. Ceccato F, Barbot M, Zilio M, et al. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency. Eur J Endocrinol. 2013;169:31-36.
36. Attia J. Moving beyond sensitivity and specificity: using likelihood ratios to help interpret diagnostic tests. Australian Prescriber. 2003; 26:111-113.
37. Alexandraki KI, Grossman A B. Is urinary free cortisol of value in the diagnosis of Cushing's syndrome? Curr Opin Endocrinol Diabetes Obes. 2011;18:259-263.
38. Smith RE, Maguire JA, Stein-Oakley AN, et al. Localization o f 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. J Clin Endocrinol Metab. 1996;81:3244-3248.
39. Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC. Latenight salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay. Clin Endocrinol (Oxf). 2012;76:467-472.
40. Raff H. Cushing's syndrome: diagnosis and surveillance using salivary cortisol. Pituitary. 2012;15:64-70.